INS and diabetes mellitus: If risk of breast (and other) cancer is significantly increased in the protracted period when hyperinsulinemia is present before diabetes diagnosis, as well as the strong association between hyperinsulinemia and the metabolic syndrome, countless lives might be saved because more than 25% of the world's adult population would benefit from metformin's ability to reduce the insulin-related risk of cancer and cancer-related mortality.